- Home
- SLGL vs IAE Comparison
SLGL vs IAE Comparison
Compare SLGL & IAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLGL
- IAE
- Stock Information
- Founded
- SLGL 1997
- IAE 2007
- Country
- SLGL Israel
- IAE United States
- Employees
- SLGL N/A
- IAE N/A
- Industry
- SLGL Biotechnology: Pharmaceutical Preparations
- IAE Trusts Except Educational Religious and Charitable
- Sector
- SLGL Health Care
- IAE Finance
- Exchange
- SLGL Nasdaq
- IAE Nasdaq
- Market Cap
- SLGL 69.1M
- IAE 82.2M
- IPO Year
- SLGL 2018
- IAE N/A
- Fundamental
- Price
- SLGL $37.00
- IAE $7.73
- Analyst Decision
- SLGL Strong Buy
- IAE
- Analyst Count
- SLGL 1
- IAE 0
- Target Price
- SLGL $50.00
- IAE N/A
- AVG Volume (30 Days)
- SLGL 16.8K
- IAE 46.3K
- Earning Date
- SLGL 11-14-2025
- IAE 01-01-0001
- Dividend Yield
- SLGL N/A
- IAE 10.21%
- EPS Growth
- SLGL N/A
- IAE N/A
- EPS
- SLGL N/A
- IAE N/A
- Revenue
- SLGL $23,931,000.00
- IAE N/A
- Revenue This Year
- SLGL N/A
- IAE N/A
- Revenue Next Year
- SLGL $31.17
- IAE N/A
- P/E Ratio
- SLGL N/A
- IAE N/A
- Revenue Growth
- SLGL 264.86
- IAE N/A
- 52 Week Low
- SLGL $4.01
- IAE $5.31
- 52 Week High
- SLGL $52.26
- IAE $6.45
- Technical
- Relative Strength Index (RSI)
- SLGL 53.73
- IAE 66.96
- Support Level
- SLGL $38.01
- IAE $7.32
- Resistance Level
- SLGL $42.00
- IAE $7.94
- Average True Range (ATR)
- SLGL 3.42
- IAE 0.14
- MACD
- SLGL -0.95
- IAE 0.04
- Stochastic Oscillator
- SLGL 30.02
- IAE 96.15
About SLGL Sol-Gel Technologies Ltd.
Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted.
About IAE Voya Asia Pacific High Dividend Equity Income Fund ING Asia Pacific High Dividend Equity Income Fund of Beneficial Interest
Voya Asia Pacific High Dividend Equity Income Fund is a United States-based diversified, closed-end fund.The investment objective of the fund is to provide a total return through a combination of current income, capital gains, and capital appreciation. To achieve this objective, under normal market conditions, the fund invests in a portfolio of dividend-yielding equity securities of companies located in the Asia Pacific region.